Last reviewed · How we verify

NCT04648215

Lavender Aromatherapy for Sleep in Hospitalized Adult Patients

Terminated NA Last updated 6 May 2023
What this trial tests

NA trial testing lavender oil in Sleep in 108 participants. Terminated before completion.

Timeline
22 February 2021
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorNorthwell Health
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment108
Start date22 February 2021
Primary completion31 December 2022
Estimated completion31 December 2022
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Northwell Health — full company profile →

Who can join

18 and older, any sex, with Sleep or Hospitalization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This feasibility study's aim is to determine the effectiveness of lavender oil aromatherapy on quality and duration of sleep in hospitalized adult patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of lavender oil

Trials testing the same drug.

Other recruiting trials for Sleep

Currently open trials in the same condition.

Other Northwell Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04648215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing